Free Trial
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free OCEAW Stock Alerts

Ocean Biomedical (OCEAW) Competitors

$0.0005 0.00 (0.00%)
As of 05/4/2026
Compare

OCEAW vs. AIMDW, ALVOW, ACABW, RNA, and BFRIW

Should you be buying Ocean Biomedical stock or one of its competitors? The main competitors of Ocean Biomedical include Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Avidity Biosciences (RNA), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Ocean Biomedical compare to Ainos?

Ainos (NASDAQ:AIMDW) and Ocean Biomedical (NASDAQ:OCEAW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

In the previous week, Ainos' average media sentiment score of 0.00 equaled Ocean Biomedical'saverage media sentiment score.

Company Overall Sentiment
Ainos Neutral
Ocean Biomedical Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$124.16KN/AN/AN/AN/A
Ocean BiomedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Ocean Biomedical N/A N/A N/A

Summary

Ainos beats Ocean Biomedical on 1 of the 1 factors compared between the two stocks.

How does Ocean Biomedical compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Ocean Biomedical (NASDAQ:OCEAW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

In the previous week, Alvotech's average media sentiment score of 0.00 equaled Ocean Biomedical'saverage media sentiment score.

Company Overall Sentiment
Alvotech Neutral
Ocean Biomedical Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
Ocean BiomedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Ocean Biomedical N/A N/A N/A

Summary

Alvotech beats Ocean Biomedical on 1 of the 1 factors compared between the two stocks.

How does Ocean Biomedical compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Ocean Biomedical (NASDAQ:OCEAW) are both pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Ocean Biomedical'saverage media sentiment score.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Ocean Biomedical Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Ocean BiomedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Ocean Biomedical N/A N/A N/A

Summary

Atlantic Coastal Acquisition Corp. II and Ocean Biomedical tied by winning 0 of the 0 factors compared between the two stocks.

How does Ocean Biomedical compare to Avidity Biosciences?

Ocean Biomedical (NASDAQ:OCEAW) and Avidity Biosciences (NASDAQ:RNA) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, institutional ownership, risk and profitability.

Avidity Biosciences has a consensus target price of $69.42, indicating a potential upside of 437.73%. Given Avidity Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Avidity Biosciences is more favorable than Ocean Biomedical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ocean Biomedical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Avidity Biosciences
1 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.32

In the previous week, Avidity Biosciences had 1 more articles in the media than Ocean Biomedical. MarketBeat recorded 1 mentions for Avidity Biosciences and 0 mentions for Ocean Biomedical. Ocean Biomedical's average media sentiment score of 0.00 equaled Avidity Biosciences'average media sentiment score.

Company Overall Sentiment
Ocean Biomedical Neutral
Avidity Biosciences Neutral

Ocean Biomedical has higher earnings, but lower revenue than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Avidity Biosciences$18.62MN/A-$322.30MN/AN/A

Ocean Biomedical has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Ocean Biomedical's return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Avidity Biosciences -3,650.39%-44.92%-39.57%

Summary

Avidity Biosciences beats Ocean Biomedical on 6 of the 9 factors compared between the two stocks.

How does Ocean Biomedical compare to Biofrontera?

Ocean Biomedical (NASDAQ:OCEAW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, institutional ownership, risk and profitability.

In the previous week, Biofrontera had 1 more articles in the media than Ocean Biomedical. MarketBeat recorded 1 mentions for Biofrontera and 0 mentions for Ocean Biomedical. Ocean Biomedical's average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score.

Company Overall Sentiment
Ocean Biomedical Neutral
Biofrontera Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Biofrontera$41.71MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Biofrontera N/A N/A N/A

Summary

Biofrontera beats Ocean Biomedical on 2 of the 2 factors compared between the two stocks.

Get Ocean Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCEAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OCEAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OCEAW vs. The Competition

Export
MetricOcean BiomedicalBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$451.91M$6.25B$11.77B
Dividend YieldN/A3.86%2.74%5.26%
P/E RatioN/A4.1429.2527.07
Price / SalesN/A6,879.71504.6873.47
Price / CashN/A13.1343.3053.90
Price / BookN/A77.749.676.69
Net IncomeN/A-$96.07M$3.55B$332.64M
7 Day PerformanceN/A0.71%1.70%2.01%
1 Month PerformanceN/A3.87%5.62%9.19%
1 Year PerformanceN/A48.54%34.42%39.59%

Ocean Biomedical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OCEAW
Ocean Biomedical
N/A$0.00
flat		N/AN/A$0.00N/AN/A2
AIMDW
Ainos
N/A$0.09
-17.7%		N/AN/A$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.28
+29.4%		N/AN/A$0.00$586.32MN/A4
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15
RNA
Avidity Biosciences
1.3232 of 5 stars		$12.91
+0.3%		$69.42
+437.7%		N/A$0.00$18.62MN/A190

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:OCEAW) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel